Gadoxetate-enhanced dynamic contrast-enhanced MRI for evaluation of liver function and liver fibrosis in preclinical trials

Jimi Huh, Su Jung Ham, Young Chul Cho, Bumwoo Park, Bohyun Kim, Chul Woong Woo, Yoonseok Choi, Dong Cheol Woo, Kyung Won Kim

    Research output: Contribution to journalArticlepeer-review

    9 Scopus citations

    Abstract

    Background: To facilitate translational drug development for liver fibrosis, preclinical trials need to be run in parallel with clinical research. Liver function estimation by gadoxetate-enhanced dynamic contrast-enhanced MRI (DCE-MRI) is being established in clinical research, but still rarely used in preclinical trials. We aimed to evaluate feasibility of DCE-MRI indices as translatable biomarkers in a liver fibrosis animal model. Methods: Liver fibrosis was induced in Sprague-Dawley rats by thioacetamide (200 mg, 150 mg, and saline for the high-dose, low-dose, and control groups, respectively). Subsequently, DCE-MRI was performed to measure: Relative liver enhancement at 3-min (RLE-3), RLE-15, initial area-under-the-curve until 3-min (iAUC-3), iAUC-15, and maximum-enhancement (Emax). The correlation coefficients between these MRI indices and the histologic collagen area, indocyanine green retention at 15-min (ICG-R15), and shear wave elastography (SWE) were calculated. Diagnostic performance to diagnose liver fibrosis was also evaluated by receiver-operating-characteristic (ROC) analysis. Results: Animal model was successful in that the collagen area of the liver was the largest in the high-dose group, followed by the low-dose group and control group. The correlation between the DCE-MRI indices and collagen area was high for iAUC-15, Emax, iAUC-3, and RLE-3 but moderate for RLE-15 (r,-0.81,-0.81,-0.78,-0.80, and-0.51, respectively). The DCE-MRI indices showed moderate correlation with ICG-R15: The highest for iAUC-15, followed by iAUC-3, RLE-3, Emax, and RLE-15 (r,-0.65,-0.63,-0.62,-0.58, and-0.56, respectively). The correlation coefficients between DCE-MRI indices and SWE ranged from-0.59 to-0.28. The diagnostic accuracy of RLE-3, iAUC-3, iAUC-15, and Emax was 100% (AUROC 1.000), whereas those of RLE-15 and SWE were relatively low (AUROC 0.777, 0.848, respectively). Conclusion: Among the gadoxetate-enhanced DCE-MRI indices, iAUC-15 and iAUC-3 might be bidirectional translatable biomarkers between preclinical and clinical research for evaluating histopathologic liver fibrosis and physiologic liver functions in a non-invasive manner.

    Original languageEnglish
    Article number89
    JournalBMC Medical Imaging
    Volume19
    Issue number1
    DOIs
    StatePublished - 15 Nov 2019

    Bibliographical note

    Publisher Copyright:
    © 2019 The Author(s).

    Keywords

    • Dynamic contrast-enhanced
    • Gadoxetate
    • Liver fibrosis
    • Liver function
    • Magnetic resonance imaging

    Fingerprint

    Dive into the research topics of 'Gadoxetate-enhanced dynamic contrast-enhanced MRI for evaluation of liver function and liver fibrosis in preclinical trials'. Together they form a unique fingerprint.

    Cite this